![John Maslowski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Maslowski
Chief Executive Officer at
Forge Biologics, Inc.
Net worth: 310 200 $ as of 29/06/2026
Profile
John M.
Maslowski is President, Chief Executive Officer & Director at Forge Biologics, Inc. since 2024.
He is Director at Nionyx Bio, Inc. starting in 2025.
He is Director at Dystrophic Epidermolysis Bullosa Research Association of America, Inc. since 2024.
He is Independent Director at Research Alliance Corp.
IV starting in 2026.
Formerly, Mr. Maslowski was President & Chief Executive Officer at Fibrocell Science, Inc. from 2019 to 2020.
He was Director at Alliance for Regenerative Medicine from 2019 to 2024.
He was Manager-Quality Assurance Investigations at Wyeth Pharmaceuticals LLC in 2005.
He was Chief Operating Officer at Castle Creek Biosciences, Inc. in 2021.
Education includes undergraduate studies at Ursinus College and graduate studies at Villanova University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
2.27% | 12/07/2026 | 30,000 ( 2.27% ) | 310 200 $ | 29/06/2026 |
John Maslowski active positions
| Companies | Position | Start |
|---|---|---|
Forge Biologics, Inc.
 Forge Biologics, Inc. BiotechnologyHealth Technology Operates as a hybrid gene therapy contract manufacturing and clinical-stage therapeutics development company | Chief Executive Officer | 30/09/2024 |
Dystrophic Epidermolysis Bullosa Rsch Assoc of America, Inc.
 Dystrophic Epidermolysis Bullosa Rsch Assoc of America, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that provides care and support services for people living with epidermolysis bullosa | Director/Board Member | 30/06/2024 |
Former positions of John Maslowski
| Companies | Position | End |
|---|---|---|
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Director/Board Member | 30/11/2024 |
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Chief Executive Officer | 19/04/2021 |
| FIBROCELL SCIENCE, INC. | Chief Executive Officer | 31/12/2019 |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Corporate Officer/Principal | 31/12/2004 |
Training of John Maslowski
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
60
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Fibrocell Science, Inc.
 Fibrocell Science, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an autologous cell and gene therapy company focused on development of personalized biologics to treat rare skin and connective tissue diseases | Commercial Services |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
Ursinus College
 Ursinus College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dystrophic Epidermolysis Bullosa Rsch Assoc of America, Inc.
Dystrophic Epidermolysis Bullosa Rsch Assoc of America, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that provides care and support services for people living with epidermolysis bullosa | Commercial Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Health Technology |
Forge Biologics, Inc.
Forge Biologics, Inc. BiotechnologyHealth Technology Operates as a hybrid gene therapy contract manufacturing and clinical-stage therapeutics development company | Health Technology |
- Stock Market
- Insiders
- John Maslowski
